Preeclampsia
661
102
122
306
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
47 trials with published results (7%)
Research Maturity
306 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.7%
31 terminated out of 661 trials
90.8%
+4.3% vs benchmark
14%
93 trials in Phase 3/4
15%
47 of 306 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 306 completed trials
Clinical Trials (661)
Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia
Mobile Health Program for Post-Preeclampsia Hypertension
Mortality Outcome of Controlled Hypertension
Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Pregnant Women With Hypertensive Disorders of Pregnancy
Placental Biology in Health and Disease
Low Dose Aspirin Alerts in High-Risk Pregnancies
Vitamin D Therapy to Prevent Recurrent Preeclampsia in High-Risk Pregnancies
Preventing Obstetric Complications With Dietary Intervention
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
Preeclampsia Postpartum Antihypertensive Treatment
Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks
Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant Women
Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.
Brain Health in Midlife
Identification of Genes of Interest for Severe Forms of Preeclampsia
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Gestational Changes in Hemodynamics and Respiratory Mechanics in Association With Pre-Eclampsia
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
Exosome Cargo From Preeclampsia Patients
LEARNER- Low dosE AspiRiN prEterm tRial (Angola)